6 minutes agoModernna begins testing new anti vaccine CO VID-19
Periskopi(5 years ago)
(5 years ago)Moderna has made it known today that she had performed her first patients in an early study of a new vaccine candidate. CO VID-19 for assessment as a generation to come. The American company has said that its new candidate, MRNA-1283, can be stored in refrigerators instead of [...]
The American company has said its new candidate, MRNA-1283, can be stored in refrigerators instead of freezings, making distribution easier, especially in developing countries.
The study of the early phase will assess the security and immunogeneticity of mRNA-1283 on three levels of dosage and give healthy adults either a single dose or in two doses of 28 days away, the statement said.
Last week, Moderna started dominating first participants in a study proving her vaccine candidates CO VID-19, broadcast Reuters.
